Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Arena Pharmaceuticals

< Previous 1 2 3 4 Next >
40 Stocks Moving In Monday's Mid-Day Session
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Arena Pharmaceuticals (NASDAQ:ARNA... 
Via Benzinga
AMC, GME: What Investors Are Saying as the Top 2 Meme Stocks Tumble Today
AMC Entertainment (AMC) and GameStop (GME) are taking a beating today and traders of the meme stocks are reacting on social media. 
Via InvestorPlace
GPRO Stock Price Prediction: Why One Analyst Is Raising Its GoPro Target
GoPro (GPRO) stock is rising higher on Monday thanks to a new upgrade and price prediction from Wedbush analyst Alicia Reese. 
Via InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today
Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE). 
Via InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pfizer Stock Up, Arena Stock Soars On $6.7 Billion Merger Deal
Pfizer stock was up while Arena stock soared Monday after Pfizer announced it is acquiring Arena for $100 a share in a $6.7 billion deal. 
Via Investor's Business Daily
Why Pfizer Shares Are Trading Higher Today
Pfizer Inc (NYSE: PFE) is trading higher Monday after UBS upgraded the stock and raised its price target. UBS analyst Colin Bristow upgraded Pfizer from a Neutral rating... 
Via Benzinga
Why Arena Pharmaceuticals Stock Is Soaring Today
Arena Pharmaceuticals Inc (NASDAQ: ARNA) is soaring Monday morning after Pfizer Inc (NYSE: PFE) announced it would acquire the company for $100 per share. The all-cash... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Arena Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Arena Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARNA
From Halper Sadeh LLP
Via Business Wire
Investors Appear to Get Defensive as the Consumer Staples Sector Breakout on Friday
Equity index futures are pointing slightly higher on Monday morning as investors appear to be a little tentative ahead of the Fed meeting later this week. Friday’s Consumer... 
Via Benzinga
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Arena Pharmaceuticals (NASDAQ:ARNA) stock moved upwards by 91.22% to $95.5 during Monday's pre-market session. The company's market cap stands at $5.8... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday! 
Via InvestorPlace
After Blood Cancer, Pfizer Now Bolsters Its Inflammatory Diseases Pipeline With $6.7B Arena Deal
Pfizer Inc (NYSE: PFE) has agreed to acquire Arena Pharmaceuticals Inc (NASDAQ: ARNA), a clinical-stage company developing therapies to treat several immuno-... 
Via Benzinga
Pfizer to Acquire Arena Pharmaceuticals
From Pfizer Inc.
Via Business Wire
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study A
From Arena Pharmaceuticals, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense?
Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuatio... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Arena Pharmaceuticals, Inc.
Via Business Wire
Arena Pharmaceuticals, inc (ARNA) Q3 2021 Earnings Call Transcript
ARNA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Arena Reports Third Quarter Financial Results and Key Program Updates
From Arena Pharmaceuticals, Inc.
Via Business Wire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Arena Pharmaceuticals, Inc.
Via Business Wire
Arena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4
From Arena Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Arena Pharmaceuticals, Inc.
Via Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Arena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor Conferences
From Arena Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.